Taubert Jennifer L
EVP, WWC. Innovative Medicine
Taubert Jennifer L has filed 3 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Taubert Jennifer L is listed as EVP, WWC. Innovative Medicine at JOHNSON & JOHNSON. Inside the rolling window, Taubert Jennifer L reported no open-market purchases and 1 open-market sale totaling $4.0M in JNJ.
Companies traded
Other insiders at JNJ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 4, 2025 | JNJ | Sale | $10.0M |
Frequently asked questions
How many SEC Form 4 filings has Taubert Jennifer L made?
Taubert Jennifer L has filed 3 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.
Which companies does Taubert Jennifer L trade?
Taubert Jennifer L has filed SEC Form 4 disclosures for 1 company, including JNJ.
When was Taubert Jennifer L's most recent SEC Form 4 filing?
Taubert Jennifer L's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Taubert Jennifer L's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Taubert Jennifer L is listed as EVP, WWC. Innovative Medicine.
What is Taubert Jennifer L's total buy and sell value in the current window?
Inside the rolling retention window, Taubert Jennifer L bought $0 and sold $4.0M based on SEC Form 4 filings.
What was Taubert Jennifer L's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 JNJ shares on 2026-08-17, worth $4.0M, per SEC Form 4 filings.